Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Jessen

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
MMW Fortschritte Der Medizin|June 5, 2016
[HIV & relationship - what if only one of the partners is HIV positive?]Heiko Jessen
Deutsches Arzteblatt International|August 1, 2022
Monkeypox in GermanyChristian Hoffmann, Heiko Jessen, Christoph Boesecke
The New England Journal of Medicine|February 14, 2014
How a single patient influenced HIV research--15-year follow-upHeiko Jessen, Todd M Allen, Hendrik Streeck
Infection|September 20, 2022
Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination?Christian Hoffmann, Eva Wolf, Heiko Jessen, et al.
Neurology|December 23, 2016
Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot studyFelix Kleefeld, Sophie Heller, Heiko Jessen, et al.
Biochemical and Biophysical Research Communications|May 23, 2015
Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infectionMacdonald Mahiti, Zabrina L Brumme, Heiko Jessen, et al.
Plos One|December 20, 2016
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient ClinicVictor Marin-Webb, Heiko Jessen, Ute Kopp, et al.
Virus Genes|August 13, 2016
Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon(®)) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapyVladimir A Morozov, Alexei V Morozov, Dirk Schürmann, et al.
Virus Genes|April 19, 2007
Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapyVladimir A Morozov, Alexei V Morozov, Dirk Schürmann, et al.
Journal of the International AIDS Society|October 5, 2019
Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional studyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
MMW Fortschritte Der Medizin|June 5, 2016
[HIV & relationship - what if only one of the partners is HIV positive?]Heiko Jessen
Deutsches Arzteblatt International|August 1, 2022
Monkeypox in GermanyChristian Hoffmann, Heiko Jessen, Christoph Boesecke
The New England Journal of Medicine|February 14, 2014
How a single patient influenced HIV research--15-year follow-upHeiko Jessen, Todd M Allen, Hendrik Streeck
Infection|September 20, 2022
Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination?Christian Hoffmann, Eva Wolf, Heiko Jessen, et al.
Neurology|December 23, 2016
Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot studyFelix Kleefeld, Sophie Heller, Heiko Jessen, et al.
Biochemical and Biophysical Research Communications|May 23, 2015
Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infectionMacdonald Mahiti, Zabrina L Brumme, Heiko Jessen, et al.
Plos One|December 20, 2016
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient ClinicVictor Marin-Webb, Heiko Jessen, Ute Kopp, et al.
Virus Genes|August 13, 2016
Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon(®)) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapyVladimir A Morozov, Alexei V Morozov, Dirk Schürmann, et al.
Virus Genes|April 19, 2007
Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapyVladimir A Morozov, Alexei V Morozov, Dirk Schürmann, et al.
Journal of the International AIDS Society|October 5, 2019
Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional studyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
Pageof 8